Benfotiamine Counteracts Smoking-Induced Vascular Dysfunction in Healthy Smokers

Figure 1

FMD without benfotiamine pretreatment: before smoking (BS (−)) and after smoking (AS(−)), and with benfotiamine pretreatment: before smoking (BS (+)), and after smoking (AS(+)), (**𝑃<0.001 versus baseline, *𝑃<0.05 versus baseline, ^§𝑃<0.05 with versus without benfotiamine).